Matarin Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-54,157
| Closed | -$4.58M | – | 277 |
|
|
2018
Q4 | $4.58M | Sell |
54,157
-9,243
| -15% | -$782K | 0.37% | 98 |
|
|
2018
Q3 | $10.9M | Sell |
63,400
-2,645
| -4% | -$453K | 0.7% | 58 |
|
|
2018
Q2 | $8.54M | Sell |
66,045
-8,823
| -12% | -$1.14M | 0.62% | 66 |
|
|
2018
Q1 | $7.71M | Sell |
74,868
-1,534
| -2% | -$158K | 0.58% | 65 |
|
|
2017
Q4 | $6.53M | Buy |
76,402
+33,398
| +78% | +$2.85M | 0.51% | 70 |
|
|
2017
Q3 | $3.65M | Buy |
43,004
+18,677
| +77% | +$1.59M | 0.31% | 130 |
|
|
2017
Q2 | $1.84M | Sell |
24,327
-39,463
| -62% | -$2.99M | 0.17% | 159 |
|
|
2017
Q1 | $4.21M | Sell |
63,790
-17,838
| -22% | -$1.18M | 0.41% | 89 |
|
|
2016
Q4 | $5.17M | Sell |
81,628
-26,764
| -25% | -$1.7M | 0.58% | 55 |
|
|
2016
Q3 | $6.9M | Buy |
108,392
+4,827
| +5% | +$307K | 0.76% | 41 |
|
|
2016
Q2 | $7.71M | Buy |
103,565
+46,803
| +82% | +$3.48M | 1.05% | 12 |
|
|
2016
Q1 | $3.79M | Buy |
56,762
+27,733
| +96% | +$1.85M | 0.53% | 81 |
|
|
2015
Q4 | $1.96M | Buy |
29,029
+24,159
| +496% | +$1.63M | 0.29% | 130 |
|
|
2015
Q3 | $260K | Buy |
+4,870
| New | +$260K | 0.05% | 201 |
|
|
2014
Q3 | – | Sell |
-25,167
| Closed | -$978K | – | 176 |
|
|
2014
Q2 | $978K | Buy |
25,167
+7,749
| +44% | +$301K | 0.44% | 106 |
|
|
2014
Q1 | $731K | Sell |
17,418
-199
| -1% | -$8.35K | 0.43% | 86 |
|
|
2013
Q4 | $578K | Buy |
+17,617
| New | +$578K | 0.36% | 98 |
|